Sotorasib

Lumykras 120 MG Comprimidos Recubiertos con Pelicula

120 mg comprimido recubierto con películaSpainAuthorisedAuthorised 11 May 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

LumykrasEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sotorasib

Lumykras 120 MG Comprimidos Recubiertos con Pelicula

120 mg comprimido recubierto con películaSpainAuthorisedAuthorised 11 May 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

LumykrasEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LumakrasCanada · 120 MG · Tablet · Amgen Canada INC

Lumakras Film-Coated Tablet 120MGSingapore · 120mg · tablet, film coated · Amgen Biotechnology Singapore Pte LTD

Lumakras Film-Coated Tablet 240MGSingapore · 240mg · tablet, film coated · Amgen Biotechnology Singapore Pte LTD

LumakrasUnited States · 120MG, 240MG, 320MG · tablet · Amgen INC

LumakrasBrazil · Amgen Biotecnologia do Brasil Ltda.

LumakrasSaudi Arabia · Patheon Inc.

Packs

Pack	Code	Status
LUMYKRAS 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 240 comprimidos	739028

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sotorasib
Strength: 120 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 11 May 2022
Registration: 1211603001
Marketing authorisation holder: Amgen Europe B.V.
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/21/1603